Nuveen Asset Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $945K | Sell |
546,414
-20,436
| -4% | -$35.4K | ﹤0.01% | 2736 |
|
|
2024
Q3 | $1.14M | Sell |
566,850
-512,249
| -47% | -$1.03M | ﹤0.01% | 2699 |
|
|
2024
Q2 | $2.42M | Buy |
+1,079,099
| New | +$2.42M | ﹤0.01% | 2290 |
|
|
2022
Q2 | – | Sell |
-105,426
| Closed | -$665K | – | 3397 |
|
|
2022
Q1 | $665K | Buy |
105,426
+2,858
| +3% | +$18K | ﹤0.01% | 2931 |
|
|
2021
Q4 | $1.2M | Buy |
102,568
+10,194
| +11% | +$119K | ﹤0.01% | 2796 |
|
|
2021
Q3 | $1.72M | Buy |
92,374
+11,952
| +15% | +$223K | ﹤0.01% | 2741 |
|
|
2021
Q2 | $1.71M | Buy |
80,422
+62,821
| +357% | +$1.33M | ﹤0.01% | 2785 |
|
|
2021
Q1 | $357K | Buy |
17,601
+3,373
| +24% | +$68.4K | ﹤0.01% | 3146 |
|
|
2020
Q4 | $378K | Buy |
+14,228
| New | +$378K | ﹤0.01% | 3100 |
|